Regencell Bioscience Holdings Ltd banner

Regencell Bioscience Holdings Ltd
NASDAQ:RGC

Watchlist Manager
Regencell Bioscience Holdings Ltd Logo
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
Watchlist
Price: 28.82 USD 2.31% Market Closed
Market Cap: $14.3B

Regencell Bioscience Holdings Ltd
Investor Relations

Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. The company employs 13 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Yat-Gai Au
Founder, Chairman & CEO
No Bio Available
Ms. Michelle Chan
Financial Controller & Principal Financial Officer
No Bio Available
Mr. Wai Hong Chung
COO, Chief Strategy Officer & Director
No Bio Available
Ms. Antonia Assang
Senior Vice President of Project Management
No Bio Available
Mr. Yat-Pui Au
Chief Business Officer
No Bio Available

Contacts

Address
11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett